Public Citizen Calls on Presidential Candidates, Parties to Pledge Not to Use Dangerous, Manipulative Deepfakes
Statement: FDA Must Reject Tanezumab as a Treatment for Osteoarthritis Due to Unacceptable Dangers, Little to No Benefit
Comments on the FDA’s Draft Guidance Regarding Evaluation of Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act May 25, 2018
Petition to the FDA to Not Allow Marketing of Over-The-Counter Benzocaine Products for Teething in Infants July 28, 2014